US Stem Cell Banking Company Receives Investment from Asia
9/3/2008 2:23:13 PM
September 3, 2008 -- NeoStem, Inc. completed a $1.25 million private placement from RimAsia Capital Partners, a pan-Asia private equity firm. This appears to be RimAsia’s first investment in a Western company. Previously, RimAsia's invested only in China-based enterprises. According to a statement from Dr. Robin Smith, Chairman and CEO of NeoStem, RimAsia is a “regional network of strategic investors drawn from leading Asian families and companies.” More details...
Stock Symbols: (AMEX: NBS)
comments powered by